Related Experiment Videos
Exploring vaccinia virus as a tool for large-scale recombinant protein expression
Nicole A Bleckwenn1, William E Bentley, Joseph Shiloach
1Biotechnology Unit, LCDB, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.
Biotechnology Progress
|February 8, 2003
Summary
This study optimized recombinant protein expression using a vaccinia virus system in HeLa cells. Key factors like multiplicity of infection and culture volume significantly enhanced enhanced green fluorescent protein (EGFP) yield.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- Recombinant protein expression is crucial for various applications.
- Optimizing expression systems is essential for efficient production.
- Vaccinia virus vectors offer a robust platform for gene expression.
Purpose of the Study:
- To engineer a recombinant vaccinia virus for enhanced green fluorescent protein (EGFP) expression.
- To evaluate production parameters for optimizing EGFP yield in HeLa cells.
- To assess the scalability of the expression system using microcarrier cultures.
Main Methods:
- Engineering a vaccinia virus to express EGFP under the T7 promoter using the VOTE system.
- Infecting HeLa cells and inducing expression with IPTG.
- Investigating the effects of multiplicity of infection (MOI), culture volume, and serum concentration.
- Utilizing Cytodex 3 microcarriers for cell growth and spinner flask cultures.
Main Results:
- Increasing MOI enhanced EGFP expression up to a plateau at MOI 1.0.
- Decreasing culture volume during infection increased EGFP expression.
- Serum concentration showed marginal significance between 0-7.5%.
- Cytodex 3 microcarriers supported optimal HeLa cell growth.
Conclusions:
- The developed vaccinia virus system effectively expresses recombinant proteins in HeLa cells.
- Optimized production parameters significantly improve EGFP yield.
- The system demonstrates scalability for larger-scale recombinant protein production.